Pipeline

Project Target Disease 2023 2024 2025
AT-01 To be disclosed Hematologic and solid tumor
ADC Optimization
Preclinical Study
Phase 1
AT-03 To be disclosed solid tumor
ADC Optimization
Preclinical Study
Phase 1
AT-04 To be disclosed solid tumor
ADC Optimization
Preclinical Study
Phase 1
AT-05 To be disclosed solid tumor
ADC Optimization
Preclinical Study